TEL. 03-3353-8111
〒162-8666 8-1, Kawada-cho, Shinjuku-ku, Tokyo
Donor transplantation has been the definitive treatment for severe diseases,
but is limited by a lack of donors and the need for immunosuppressant drug
application after transplantation. Global interest has turned to regenerative
medicine and tissue engineering to present new solutions to these problems.
Tissue engineering was proposed in 1993 by Robert Langer, an American engineer,
and Joseph Vacanti, an American surgeon, who proved that the regeneration
of the three‐dimensional tissue structure is feasible by adding cells to
a biodegradable polymer in the presence of growth factors. The further
parallel development of tissue engineering and cell biology is expected
to progress.
Regenerative medicine is interdisciplinary, achieving more than medical
science or engineering alone. This research field integrates medicine,
science and engineering to provide innovative, new concepts and approaches
for the future development of medicine.
(1)Technical development of isolation/differentiation/amplification of
stem cells
(2)Regenerative therapy with cell sheet engineering
(3)Development of new regenerative treatment using mesenchymal stem cell
sheet
(4)Application of culture epithelial cells to regenerative medicine
(5) Development of regenerative medicine using human iPS cell-derived cells
Masayuki Yamato
Katsuhisa Matsuura
Hidekazu Sekine
Ryo Takagi
Homma Jun
Shinako Aoki
Tsukasa Hara
〒162-8666
8-1, Kawada-cho, Shinjuku-ku, Tokyo
TEL +81-3-3353-8111